New York, September 14, 2015 -- Moody's Investors Service commented that it had extended its B3 rating to the proposed offering of $250 million of senior unsecured notes by Acadia Healthcare Company, Inc. The issuance has no impact on the company's other ratings. The issuance is an add-on to Acadia's existing 5.625% senior notes due 2023, which are rated B3 (LGD 5). Moody's understands that the proceeds of the offering will be used to fund the redemption of the company's remaining 12.875% senior notes due 2018 and repay amounts outstanding under its revolver.

Vollständigen Artikel bei Moodys lesen